Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-23-007503
Date:2023-02-06
Issuer: FATE THERAPEUTICS INC (FATE)
Original Submission Date:

Reporting Person:

DULAC EDWARD J III
C/O FATE THERAPEUTICS, INC.
12278 SCRIPPS SUMMIT DRIVE SAN DIEGO, CA 92131

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 6.77 2023-02-06 deemed execution date A 425,000 (a) 2033-02-05 common stock 425,000 $6.77 425,000 direct
Footnotes
IDfootnote
f1 the shares subject to this option shall vest in 36 equal monthly installments following january 1, 2023, such that all of the shares shall be fully vested and exercisable on january 1, 2026, subject to the reporting person's continued service with the issuer as of each such vesting date.
WhaleWisdom Logo

Elevate your investments